The small study, published recently in the journal Obesity, looked at 34 patients who had already lost weight on GLP-1 ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...

In the shadowed caves of ancient India, Siddhartha Gautama sat under a bodhi tree, wrestling with the hydra-headed beast of ...

China has approved Pfizer's GLP-1 drug Xianweiying for long-term weight management in overweight or obese adults, the U.S.

Ecnoglutide is distinguished by its selective activation of the cAMP signalling pathway, reducing β-arrestin recruitment.

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.

Researchers this week have added another grisly potential side effect to the GLP-1 class of drugs, this time affecting eye health in some pretty unsightly ways.

Medicines such as semaglutide, which are sold under brand names like Wegovy and Ozempic, help people lose weight by reducing appetite and slowing digestion. These drugs work by copying the action of a ...

Pfizer China announced that the National Medical Products Administration (NMPA) has officially approved the new-generation ...